Researchers discovered that two identical twin girls with severe bone disease inherited two different mutations in the CYP2R1 gene that prevents their bodies from converting vitamin D into its active form. According to Gram Research analysis, one mutation completely stopped the gene from working while the other reduced its function by about half, meaning standard vitamin D supplements couldn’t help them because their bodies couldn’t process the vitamin. This rare genetic condition, called vitamin D hydroxylation deficiency rickets type 1B, causes curved bones and walking problems and requires specialized medical treatment rather than regular supplements.

Researchers discovered that identical twin girls with a rare bone disease called vitamin D hydroxylation deficiency rickets type 1B inherited two different genetic mutations that prevent their bodies from properly processing vitamin D. According to Gram Research analysis, the girls had curved legs and trouble walking because their bodies couldn’t activate vitamin D correctly, even when taking supplements. Scientists used genetic testing to identify the specific mutations in the CYP2R1 gene and found that one mutation completely stopped the gene from working while the other reduced its function. This discovery helps doctors understand and diagnose this rare inherited condition and shows why some people don’t benefit from standard vitamin D supplements.

Key Statistics

A 2026 case study of identical twin girls found that compound heterozygous mutations in the CYP2R1 gene caused vitamin D hydroxylation deficiency rickets type 1B, with one mutation completely eliminating enzyme function and the other reducing function by approximately 50 percent.

Genetic analysis revealed that the novel frameshift mutation (c.75_76insA) in CYP2R1 produced no functional protein at all, while the second mutation (c.1115G>C) triggered cellular stress responses that partially impaired the enzyme’s ability to activate vitamin D.

The twin girls’ serum 25-hydroxyvitamin D levels remained low despite continuous vitamin D and calcium supplementation since age 6 months, and decreased to mild deficiency within one week of stopping supplements, indicating their bodies could not maintain adequate vitamin D activation.

The Quick Take

  • What they studied: Why two identical twin girls developed severe bone disease despite taking vitamin D supplements, and what genetic mutations caused their condition
  • Who participated: A pair of identical twin girls with curved legs and walking difficulties who had been taking vitamin D and calcium supplements since infancy, plus their parents
  • Key finding: The twins inherited two different mutations in the CYP2R1 gene that prevents their bodies from converting vitamin D into its active form, even when supplements are taken
  • What it means for you: If you or a family member has unexplained bone problems despite vitamin D supplementation, genetic testing for CYP2R1 mutations may reveal a rare inherited condition requiring specialized treatment rather than standard supplements

The Research Details

This research examined two identical twin girls with severe bone disease to understand why they developed rickets, a condition that weakens bones. The girls had curved legs and difficulty walking normally, and X-rays showed abnormal bone development. Researchers collected blood samples to measure vitamin D levels and performed whole genome sequencing, which is a test that reads all the genetic instructions in a person’s DNA to find mutations or errors. The scientists also studied the twins’ parents to trace where the genetic mutations came from. Additionally, laboratory experiments tested how the mutated genes functioned compared to normal genes to understand exactly how the mutations caused the disease.

This research approach is important because it combines clinical observation, genetic testing, and laboratory experiments to fully explain a rare disease. By studying identical twins, researchers could confirm that genetics, not environment, caused the condition. The whole genome sequencing identified the specific genetic mutations responsible, and the laboratory work proved how those mutations damaged the gene’s function. This comprehensive approach helps doctors recognize similar cases and develop better treatments.

This study is a detailed case report of two patients, which means it provides in-depth information about specific individuals rather than comparing large groups. The strength of this study is the thorough genetic analysis and laboratory confirmation of how the mutations work. The limitation is that it involves only two people, so findings may not apply to everyone with similar symptoms. The research was published in a peer-reviewed medical journal, meaning other experts reviewed the work before publication.

What the Results Show

The twin girls had low vitamin D levels that worsened quickly when they stopped taking supplements, indicating their bodies couldn’t maintain vitamin D properly. Genetic testing revealed that each twin inherited two different mutations in the CYP2R1 gene, one from each parent. The first mutation, called a frameshift variant, completely prevented the gene from producing a working protein. The second mutation allowed some protein to be made, but it was unstable and didn’t function well. Laboratory tests confirmed that the first mutation produced no active enzyme at all, while the second mutation produced only partial function. Together, these two mutations meant the twins’ bodies couldn’t convert vitamin D into its active form, which is essential for bone health.

The research identified a new mutation type (the frameshift variant) that hadn’t been previously documented in medical literature, expanding the known spectrum of CYP2R1 mutations. The study showed that the second mutation activated a cellular stress response called unfolded protein response signaling, which damaged the protein’s ability to function. The twins’ clinical presentation with curved legs and delayed walking matched the genetic findings, confirming the diagnosis. The study demonstrated that standard vitamin D supplementation alone cannot help people with this specific genetic defect because their bodies cannot activate the vitamin D, regardless of how much they take.

Vitamin D hydroxylation deficiency rickets type 1B is a known rare genetic disease, but this case report adds new information about the types of mutations that can cause it. Previous research identified other CYP2R1 mutations, but this study documents a novel frameshift mutation not previously reported. The findings confirm that the disease follows an autosomal recessive inheritance pattern, meaning a person must inherit two mutated copies of the gene to develop the condition. This case supports existing knowledge that people with this genetic defect need specialized treatment beyond standard vitamin D supplements.

This study examined only two patients, so the findings may not apply to all people with CYP2R1 mutations or similar bone diseases. The research is a case report rather than a controlled trial, meaning there’s no comparison group to measure against. The study doesn’t provide long-term follow-up data on how the twins responded to specialized treatment. The laboratory experiments were conducted in test tubes rather than in living organisms, so results may differ in actual human bodies. Additionally, the study doesn’t examine whether other genetic or environmental factors might influence how the disease develops in different people.

The Bottom Line

People with unexplained rickets or bone disease despite vitamin D supplementation should ask their doctor about genetic testing for CYP2R1 mutations. If mutations are found, specialized medical treatment beyond standard supplements is needed. Family members of affected individuals should consider genetic counseling and testing since the condition is inherited. This recommendation has moderate confidence because it’s based on a detailed case study rather than large population research, but the genetic findings are clear and reproducible.

This research matters most for people with unexplained bone disease, especially children with curved legs or delayed walking who haven’t improved with standard vitamin D treatment. Family members of affected individuals should pay attention because the condition is inherited. Doctors and genetic counselors should know about this research to help diagnose similar cases. People with normal vitamin D levels and no bone disease don’t need to worry about this rare condition.

Recognizing this genetic condition typically takes time because rickets symptoms appear gradually during childhood. Once diagnosed through genetic testing, specialized treatment can begin immediately, but bone changes that already occurred may not fully reverse. Improvement in bone health and walking ability may take months to years depending on the severity of existing damage and how well the specialized treatment works. Early diagnosis and treatment in infancy provides the best chance for normal bone development.

Frequently Asked Questions

What is vitamin D hydroxylation deficiency rickets and why is it different from regular rickets?

Vitamin D hydroxylation deficiency rickets type 1B is a rare genetic disease where the body cannot activate vitamin D properly due to mutations in the CYP2R1 gene. Unlike regular rickets caused by vitamin D deficiency, this condition doesn’t improve with standard vitamin D supplements because the body’s enzyme that activates vitamin D is broken or missing.

Can genetic testing identify if someone has CYP2R1 mutations?

Yes, whole genome sequencing can identify CYP2R1 mutations. If you have unexplained bone disease despite vitamin D treatment, ask your doctor about genetic testing. Finding these mutations confirms the diagnosis and helps determine the right specialized treatment instead of standard supplements.

If my child has curved legs and trouble walking, could they have this genetic rickets?

Curved legs and walking difficulties can have many causes, but if these symptoms persist despite vitamin D supplementation, genetic testing for CYP2R1 mutations may be appropriate. Talk to your pediatrician about whether genetic testing makes sense for your child’s specific situation.

Is vitamin D hydroxylation deficiency rickets inherited from parents?

Yes, this condition follows autosomal recessive inheritance, meaning a person must inherit two mutated copies of the CYP2R1 gene, one from each parent, to develop the disease. Parents typically carry one mutated copy but don’t show symptoms.

What treatment works for people who cannot process vitamin D normally?

People with CYP2R1 mutations need specialized medical treatment beyond standard vitamin D supplements, typically involving active vitamin D metabolites prescribed by a doctor. The specific treatment depends on the type and severity of mutations, so genetic diagnosis is essential for proper care.

Want to Apply This Research?

  • Track vitamin D supplement intake and blood vitamin D levels at regular intervals (every 3 to 6 months) to monitor whether standard supplements are working or if specialized treatment is needed
  • If genetic testing confirms CYP2R1 mutations, switch from standard vitamin D supplements to specialized treatment prescribed by your doctor, and record any improvements in bone health, walking ability, or pain levels
  • Maintain a log of bone health symptoms including leg pain, walking difficulty, or bone deformities, paired with blood test results and supplement type, to help your doctor adjust treatment and track long-term outcomes

This research describes a rare genetic condition identified in two specific patients. The findings do not apply to people with typical vitamin D deficiency or regular rickets. If you or your child has bone problems, curved legs, or delayed walking, consult with a pediatrician or orthopedic specialist for proper evaluation and diagnosis. Genetic testing should only be performed under medical supervision with appropriate genetic counseling. Do not change vitamin D supplementation or medical treatment based on this article without consulting your healthcare provider. This article is for educational purposes and does not constitute medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Study of biallelic variants in CYP2R1 causing vitamin D hydroxylation deficiency rickets type 1B. , Clinica chimica acta; international journal of clinical chemistry (2026). PubMed 42838446 | DOI
Topics
vitamin D deficiency rickets CYP2R1 gene mutations genetic bone disease autosomal recessive inheritance vitamin D hydroxylation rare genetic rickets bone health genetics vitamin D supplementation